|
End-of-day quote
Shanghai S.E.
2026-11-13
|
5-day change | 1st Jan Change | ||
| 39.22 CNY | -0.46% |
|
-2.85% | -7.83% |
| Market Cap | 12.48B 1.87B 1.69B 1.57B 1.41B 2.67B 176B 2.76B 18.83B 7.47B 94.2B 7.02B 6.87B 299B | P/E 2024 |
11.3x | P/E 2025 | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 9.88B 1.48B 1.34B 1.24B 1.12B 2.11B 139B 2.18B 14.9B 5.91B 74.52B 5.55B 5.43B 237B | EV / Sales 2024 |
3.4x | EV / Sales 2025 | 3.72x |
| Free-Float |
39.36% | Yield 2024 |
5.3% | Yield 2025 | 4.13% |
| 1 day | -0.46% | ||
| 1 week | -2.85% | ||
| Current month | +8.61% | ||
| 1 month | +6.46% | ||
| 3 months | -2.07% | ||
| 6 months | -8.49% | ||
| Current year | -7.83% |
| 1 week | 38.84 |  | 40.61 |
| 1 month | 34.85 | | 41.33 |
| Current year | 34.8 | | 46 |
| 1 year | 34.8 | | 47.27 |
| 3 years | 26.95 | | 57.98 |
| 5 years | 22.73 | | 57.98 |
| 10 years | 13.54 | | 140.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuan Dong Guo
CEO | Chief Executive Officer | 56 | 2014-11-19 |
Jun Chen
DFI | Director of Finance/CFO | 48 | 2019-10-24 |
Li Li Wen
IRC | Investor Relations Contact | 46 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Da Bin Chen
CHM | Chairman | 70 | 2015-01-07 |
Yu Cheng Zhou
BRD | Director/Board Member | 44 | 2015-01-07 |
Yuan Dong Guo
BRD | Director/Board Member | 56 | 2015-01-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.46% | -2.85% | -16.29% | -0.55% | 1.87B | |
| +1.26% | +6.61% | +41.12% | +135.59% | 1,286B | |
| +0.79% | +3.45% | +46.35% | +93.56% | 688B | |
| +0.20% | +1.28% | +27.01% | +112.80% | 521B | |
| -0.44% | +3.69% | +39.60% | +69.51% | 386B | |
| +0.55% | +0.70% | +59.00% | +44.20% | 364B | |
| -0.12% | +0.74% | +26.78% | +58.43% | 302B | |
| +0.37% | +0.37% | +3.62% | +36.44% | 287B | |
| -0.30% | +1.14% | +38.59% | +74.61% | 252B | |
| +0.08% | +0.71% | +34.25% | +124.32% | 208B | |
| Average | +0.19% | +1.49% | +30.00% | +74.89% | 430B | |
| Weighted average by Cap. | +0.54% | +2.68% | +37.61% | +96.19% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.81B 420M 381M 352M 318M 599M 39.65B 620M 4.23B 1.68B 21.18B 1.58B 1.54B 67.23B | 2.98B 447M 405M 374M 338M 637M 42.12B 659M 4.5B 1.78B 22.5B 1.68B 1.64B 71.41B |
| Net income | 1.05B 157M 143M 132M 119M 224M 14.85B 232M 1.59B 629M 7.93B 591M 578M 25.18B | 938M 141M 127M 118M 106M 200M 13.25B 207M 1.41B 561M 7.08B 527M 516M 22.46B |
| Net Debt | -2.35B -352M -319M -295M -266M -502M -33.22B -520M -3.55B -1.41B -17.74B -1.32B -1.29B -56.32B | -2.61B -391M -354M -328M -296M -557M -36.85B -577M -3.94B -1.56B -19.68B -1.47B -1.44B -62.49B |
Employees
671
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | CN¥39.22 | -0.46% | 2,883,752 |
| 26-11-12 | CN¥39.40 | +0.03% | 2,504,150 |
| 26-11-11 | CN¥39.39 | -0.10% | 1,947,675 |
| 26-11-10 | CN¥39.43 | -0.20% | 2,530,990 |
| 26-11-09 | CN¥39.51 | -2.13% | 4,263,998 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600211 Stock
Select your edition
All financial news and data tailored to specific country editions
